What is Cannabis Indica Oil Market?
Cannabis indica oil is one of the most talked about products which is derived from the indica cannabis plant, this oil contains both THC (the often-illegal psychotropic substance in marijuana) and CBD which is a legal, beneficial cannabinoid with no psychoactive effects and lots of CBD oil products to choose from. The blend of those two cannabinoids is what makes cannabis indica oil such a popular supplement these days. Indica and sativa are the two most prominent cannabis plants used for the production of medical marijuana. Indica plants are easier to grow indoors and harvest higher THC content in the products. The oil is derivative by crushing the flowers of the plants in a solvent which should be pure alcohol when done right. The flowers are washed in this solvent a few times till the most possible THC and CBD have been released from the plant matter.
The market study is being classified by Type (Organic Cannabis Oil and Non-Organic Cannabis Oil), by Application (Recreational and Medical) and major geographies with country level break-up.
Select Oil (United States), Aphria (Canada), Emblem Cannabis Oils (Canada), Canopy Growth Corporation (Canada), WHISTLER MEDICAL MARIJUANA CORPORATION (Canada) and Absolute Terps (United States) are some of the key players profiled in the study.
Research Analyst at AMA predicts that North America Players will contribute to the maximum growth of Global Cannabis Indica Oil market throughout the predicted period.
Segment Analysis
Analyst at AMA have segmented the market study of Global Cannabis Indica Oil market by Type, Application and Region.
On the basis of geography, the market of Cannabis Indica Oil has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Drivers
- High Demand for Cannabis-Related Pharmaceutical Products
- Rising Geriatric Population In Need of Treatment for Chronic Diseases
Market Trend
- Increase Government Initiatives towards Cannabis-Related Research and Development
- Growing Demand for Cannabis Testing Products
Restraints
- Fluctuation in Price and Foreign Currency Exchange Rates
- High Cost Related Within Cannabis Testing Equipment
Opportunities
- Advancement in Cultivation and Production Methods
Challenges
FDA recognizes the potential opportunities that cannabis or cannabis-derived compounds may offer and acknowledges the significant interest in these possibilities. However, FDA is aware that some companies are marketing products containing cannabis and cannabis-derived compounds in ways that violate the Federal Food, Drug and Cosmetic Act (FD&C Act) and that may put the health and safety of consumers at risk. FDA has a number of resources available that address cannabis and cannabis-derived products, such as CBD, and the agency wants to ensure that consumers and other stakeholders have access to these resources in a centralized location.
Key Target Audience
Cannabis Oil Manufacturers, Cosmetic Industry, Healthcare Industry, Regulatory Bodies, Government Bodies and Others